Using MRI and Atlas-based Volumetrics to Investigate Grey Matter Atrophy in Animal Models of Multiple Sclerosis

dc.contributor.advisorDunn, Jeff F.
dc.contributor.authorHamilton, Andrew Max
dc.contributor.committeememberYong, V. Wee
dc.contributor.committeememberForkert, Nils D.
dc.date2023-11
dc.date.accessioned2023-06-23T17:39:39Z
dc.date.available2023-06-23T17:39:39Z
dc.date.issued2023-06
dc.description.abstractLoss of brain volume known as atrophy, occurs at an accelerated rate in Multiple Sclerosis (MS) compared to healthy adults and is closely associated with clinical disability and disease progression. To better understand and treat atrophy, mouse models that feature atrophy along with other aspects of MS pathology are needed. The objective of this thesis was to utilize magnetic resonance imaging (MRI) and atlas-based volumetrics to investigate animal models of MS for atrophy and determine if they are suitable for studying atrophy in MS. First, we investigated the experimental autoimmune encephalomyelitis (EAE) model commonly used to study neuroinflammation in MS. EAE mice had lower brain volumes at chronic long-term disease duration with atrophy identified in both white (WM) and grey matter (GM) regions including the cerebral cortex, cerebellum, hippocampus, corpus callosum, basal forebrain, midbrain, optic tract, and colliculus. Like MS, atrophy was associated with neurodegeneration and long-term physical disability. Next, to validate these results, we measured atrophy in EAE along with cerebral blood flow (CBF), another aspect of MS pathology possibly associated with atrophy. Using continuous arterial spin labelling MRI, we observed a reduction in cortical CBF at peak clinical disease and long-term disease in EAE. Reduced CBF at peak clinical disease appears to be related to systemic inflammation and blood brain barrier breakdown as reduced CBF was also seen in the systemic inflammation controls. Reduced CBF at long-term was instead correlated with atrophy. Finally, we investigated the cuprizone model, commonly used to study demyelination. Following chronic demyelination, atrophy was seen in WM and subcortical GM regions including the corpus callosum, internal capsule, stria terminalis, striatum, thalamus, and globus pallidus. Atrophy coincided with demyelination, and WM axonal injury, but not neuronal or axonal loss. This lack of neuroaxonal loss suggests demyelination alone is not sufficient to cause neurodegeneration and the inflammatory infiltration seen in EAE and MS may be necessary. Overall, this thesis provides a foundation for future studies into atrophy in animal models of MS and demonstrates the utility of our methods for assessing neuroprotective therapies or investigating the pathophysiology behind atrophy in MS.
dc.identifier.citationHamilton, A. M. (2023). Using MRI and atlas-based volumetrics to investigate grey matter atrophy in animal models of Multiple Sclerosis (Doctoral thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.
dc.identifier.urihttps://hdl.handle.net/1880/116648
dc.identifier.urihttps://dx.doi.org/10.11575/PRISM/41491
dc.language.isoen
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgary
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectMultiple Sclerosis (MS)
dc.subjectMagnetic Resonance Imaging (MRI)
dc.subjectExperimental Autoimmune Encephalomyelitis (EAE)
dc.subjectCuprizone
dc.subjectAtrophy
dc.subjectAtlas-based Volumetrics
dc.subjectCerebral Blood Flow
dc.subject.classificationNeuroscience
dc.subject.classificationRadiology
dc.subject.classificationBiophysics--Medical
dc.titleUsing MRI and Atlas-based Volumetrics to Investigate Grey Matter Atrophy in Animal Models of Multiple Sclerosis
dc.typedoctoral thesis
thesis.degree.disciplineMedicine – Neuroscience
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameDoctor of Philosophy (PhD)
ucalgary.thesis.accesssetbystudentI do not require a thesis withhold – my thesis will have open access and can be viewed and downloaded publicly as soon as possible.
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2023_hamilton_andrew.pdf
Size:
7.88 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description: